<code id='73DC9608BD'></code><style id='73DC9608BD'></style>
    • <acronym id='73DC9608BD'></acronym>
      <center id='73DC9608BD'><center id='73DC9608BD'><tfoot id='73DC9608BD'></tfoot></center><abbr id='73DC9608BD'><dir id='73DC9608BD'><tfoot id='73DC9608BD'></tfoot><noframes id='73DC9608BD'>

    • <optgroup id='73DC9608BD'><strike id='73DC9608BD'><sup id='73DC9608BD'></sup></strike><code id='73DC9608BD'></code></optgroup>
        1. <b id='73DC9608BD'><label id='73DC9608BD'><select id='73DC9608BD'><dt id='73DC9608BD'><span id='73DC9608BD'></span></dt></select></label></b><u id='73DC9608BD'></u>
          <i id='73DC9608BD'><strike id='73DC9608BD'><tt id='73DC9608BD'><pre id='73DC9608BD'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:3866
          Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

          WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

          CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

          advertisement

          Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Acelyrin, a rare IPO success, stumbles in its first big test
          Acelyrin, a rare IPO success, stumbles in its first big test

          MarkLennihan/APThebiotechcompanyAcelyrin,whichraisedmorethan$500millioninanIPOthisyear,ranintoitsfir

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          CDC wastewater surveillance dashboard to track bird flu hotspots

          GodofredoA.Vásquez/APReluctanceamongdairyfarmerstoreportH5N1birdfluoutbreakswithintheirherdsorallowt